Drug intelligence / Profile preview

Decrustation Ointment

Development stage: Preclinical
Lead developer: Changhai Hospital
Modality: Drug Delivery Systems
Administration: Topical

Overview

Decrustation Ointment is a topical pharmaceutical preparation, often formulated with traditional Chinese medicine (TCM) ingredients, used for the treatment of deep second-degree burns. Its primary function is to facilitate the removal of scabs (decrustation) from burn wounds, thereby promoting the natural healing process and tissue regeneration. It is currently being investigated in clinical trials for its efficacy in burn treatment.

Other names: 脱痂膏

Beyond the preview

Go deeper on Decrustation Ointment.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Decrustation Ointment.

Explore the full profile